Connective Tissue Disorders

Connective Tissue Disorders

Connective tissue disorders encompass a diverse group of conditions that affect the body’s connective tissues, including joints, skin, blood vessels, and organs. At Ramineni Hospital, we provide specialized care for several connective tissue disorders, including Systemic Lupus Erythematosus (SLE), Sjogren’s Syndrome, Systemic Sclerosis (Scleroderma), and Mixed Connective Tissue Disease (MCTD).

  • Systemic Lupus Erythematosus (SLE): Systemic Lupus Erythematosus is an autoimmune disease where the body’s immune system attacks its own tissues, leading to inflammation and damage in various organs and systems. Our team of rheumatologists at Ramineni Hospital offers comprehensive management of SLE, focusing on controlling disease activity and preventing organ damage. Treatment typically involves a combination of medications, including corticosteroids, immunosuppressants, and antimalarial drugs. Additionally, patient education and lifestyle modifications are emphasized to help individuals manage their condition effectively and improve quality of life.
  • Sjogren’s Syndrome: Sjogren’s Syndrome is a chronic autoimmune disorder characterized by inflammation of the moisture-producing glands, leading to symptoms such as dry eyes and mouth. At Ramineni Hospital, our rheumatologists collaborate with ophthalmologists and dentists to provide holistic care for Sjogren’s Syndrome patients. Treatment may include artificial tears and saliva substitutes to alleviate dryness, as well as medications to manage systemic symptoms such as joint pain and fatigue. Patient support groups and resources are also available to help individuals cope with the challenges of living with Sjogren’s Syndrome.
  • Systemic Sclerosis (Scleroderma): Systemic Sclerosis, or Scleroderma, is a rare autoimmune disease characterized by abnormal growth of connective tissue, leading to thickening and hardening of the skin and internal organs. Our multidisciplinary team at Ramineni Hospital offers specialized care for systemic sclerosis patients, focusing on symptom management and organ preservation. Treatment may include medications to reduce inflammation and control symptoms, as well as physical therapy to maintain joint mobility and prevent contractures. Close monitoring and regular assessments are essential to detect and address complications early, improving outcomes for individuals with systemic sclerosis.
  • Mixed Connective Tissue Disease (MCTD): Mixed Connective Tissue Disease is a complex autoimmune disorder with features overlapping those of various connective tissue diseases, including SLE, scleroderma, and polymyositis. Our rheumatologists at Ramineni Hospital specialize in diagnosing and managing MCTD, tailoring treatment plans to address specific symptoms and complications. Medications such as corticosteroids and immunosuppressants may be prescribed to control inflammation and prevent organ damage. Close collaboration with other specialists, including pulmonologists, cardiologists, and dermatologists, ensures comprehensive care for individuals with mixed connective tissue disease.